Adjusted Fibrinogen Replacement Strategy

NCT03444324 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

222

Enrollment

INDUSTRY

Sponsor class

Conditions

Bleeding Disorder
Hypofibrinogenemia; Acquired

Interventions

BIOLOGICAL: BT524
BIOLOGICAL: FFP/Cryo

Sponsor

Biotest

Collaborators

[object Object]
[object Object]